Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
DOT Sinks as Polkadot Fades—Is Recovery Still Possible?

DOT Sinks as Polkadot Fades—Is Recovery Still Possible?

BitgetBitget2025/06/29 12:48
By:Bitget
  • Polkadot’s user base and developer activity have dropped drastically in 2025.
  • DOT trades near key support after a 93% plunge from its all-time high.
  • Analysts warn of further losses if selling pressure continues and support levels break.

Polkadot — DOT , once promised a revolution. Now, it’s struggling just to survive. What was once a bold experiment in interoperability has turned into a fading memory. DOT has lost over 93% of its value since its peak, and the community is no longer buzzing with energy. Even longtime supporters have started to lose faith. The numbers tell a harsh story. Developers are leaving. Users are disappearing. The network is barely hanging on.

Polkadot is dead.

Raised $500M. Promised a revolution.

Now? No users. No devs. No future.

Here’s how one of crypto’s biggest bets faded into a ghost chain 👇🧵 pic.twitter.com/XMHElzhOl0

— Nonzee (@0xNonceSense) June 27, 2025

Vision Derailed, Momentum Lost

Polkadot launched with massive hype. Backed by $500 million in funding, it aimed to challenge Ethereum’s dominance . The parachain model sparked initial excitement, but that excitement quickly faded. Real-world usage failed to materialize. The fire never caught on. By 2025, daily active users had dropped to just 5,000. Developer participation plummeted from 2,400 to around 1,000. That isn’t a dip—it’s a dramatic collapse in engagement.

Trading volume followed the same bleak pattern. From a high of $39 billion, it has nosedived to just $5 billion. Investors clearly lost confidence and started looking elsewhere. Revenue figures are equally depressing. For two straight months, Polkadot earned just $462. Not $462,000—just $462. That’s less than the monthly revenue of a tiny online store. Capital didn’t just slow—it vanished. Market participants fled for ecosystems that showed real growth and innovation.

Can DOT Survive the Bleeding?

As a result, Polkadot’s share of the total crypto market shrank to a mere 0.15%. That’s barely a blip on the radar now. Analysts aren’t optimistic. DOT currently trades at $3.30, down 47% in the past 12 months. The technicals aren’t encouraging either. The RSI hovers near oversold territory, signaling relentless selling pressure. If the price drops below $3.00, support may crumble. And if $2.80 breaks, the next stop could be $2.60—or worse.

A project that once stood as Ethereum’s rival is now an afterthought. The dream lies fractured. Still, there’s a faint glimmer of hope. If bearish pressure weakens, DOT might retest the $3.60 resistance level. A breakout there could offer short-term relief, maybe even spark renewed interest. But without users and developers, it won’t mean much in the long run.

Polkadot is running out of time. The network needs a bold turnaround plan—not minor fixes. Without urgent action, it risks becoming a cautionary tale of what happens when ambition outpaces execution.This isn’t a temporary setback. It feels like a slow-motion collapse. And unless something drastic changes, Polkadot’s dream might be over for good.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. Stock IPO Preview | From Losses to Net Profit of 5.46 Million: The "Three-Dimensional" Platform Business Strategy with a Taste for Golf

Crossing the break-even line, the growth inflection point has arrived.

智通财经•2026/11/11 03:22

Core CPI Exceeds Expectations Again, Fed Hawks Loud! 2027 FOMC Voting Member Directly Calls Inflation Hot

Austan Goolsbee, President of the Chicago Federal Reserve, stated that officials must address the issue of high inflation, and described the October consumer price report as worrisome.

智通财经•2026/11/11 03:06

Weight-loss drug receives FDA warning for rare eye disease; Novo Nordisk (NVO.US) and Eli Lilly (LLY.US): No evidence of causality

The FDA requires all GLP-1 drugs to include a warning about the rare eye disease NAION. Novo Nordisk and Eli Lilly deny any causality, while Citi states that the impact on adoption is limited.

智通财经•2026/11/11 02:56
Weight-loss drug receives FDA warning for rare eye disease; Novo Nordisk (NVO.US) and Eli Lilly (LLY.US): No evidence of causality